Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Moskalev

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|June 5, 2015
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesWolfgang Jäger, Hui Xue, Tetsutaro Hayashi, et al.
Scientific Reports|September 15, 2017
Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cellsKevin J Tam, Daniel H F Hui, Wilson W Lee, et al.
EMBO Molecular Medicine|October 15, 2024
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumorsNastaran Khazamipour, Htoo Zarni Oo, Nader Al-Nakouzi, et al.
Cell Death & Disease|April 7, 2021
Development of a bispecific immune engager using a recombinant malaria proteinMie A Nordmaj, Morgan E Roberts, Emilie S Sachse, et al.
Molecular Cancer Therapeutics|September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder CancerTilman Todenhöfer, Roland Seiler, Craig Stewart, et al.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|June 5, 2015
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesWolfgang Jäger, Hui Xue, Tetsutaro Hayashi, et al.
Scientific Reports|September 15, 2017
Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cellsKevin J Tam, Daniel H F Hui, Wilson W Lee, et al.
EMBO Molecular Medicine|October 15, 2024
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumorsNastaran Khazamipour, Htoo Zarni Oo, Nader Al-Nakouzi, et al.
Cell Death & Disease|April 7, 2021
Development of a bispecific immune engager using a recombinant malaria proteinMie A Nordmaj, Morgan E Roberts, Emilie S Sachse, et al.
Molecular Cancer Therapeutics|September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder CancerTilman Todenhöfer, Roland Seiler, Craig Stewart, et al.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
Pageof 4